Should you set lower LDL targets?
According to new studies, the answer is yes. But how good is the evidence, and what should the target be for which patients?
According to new studies, the answer is yes. But how good is the evidence, and what should the target be for which patients?
The benefits of adding a second or third drug to a statin are unproven at best and may have potential downsides instead, this expert maintains. The HMG-CoA reductase inhibitors, commonly known as the “statins,” are widely used and successful therapies. Developed nearly 20 years ago, the statins’ ability to lower LDL and help prevent cardiovascular…
This unexpected event often occurs before the patient can be hospitalized or admitted to an emergency department. Find out how to prevent it. Of the 650,000 people in the United States who die of cardiovascular disease (CVD) each year, more than half are felled by sudden cardiac death (SCD), in which the patient expires within…